Abiomed To Upgrade IT Applications Of AB5000 Circulatory Support System
This article was originally published in The Gray Sheet
Executive Summary
Abiomed President and CEO Michael Minogue says the IT experience he gained in 11 years at GE Medical Systems will help to differentiate the firm's circulatory support devices from their competitors
You may also be interested in...
Abiomed Forecasts Recover Micropump U.S. Approval In 2006
Abiomed expects profitability in 2007 following U.S. approval of Recover 5.0 and 2.5 second-generation micropumps, which it acquired from Impella CardioSystems AG in April
Abiomed Forecasts Recover Micropump U.S. Approval In 2006
Abiomed expects profitability in 2007 following U.S. approval of Recover 5.0 and 2.5 second-generation micropumps, which it acquired from Impella CardioSystems AG in April
Abiomed seeks HDE approval
Danvers, Mass. firm submits humanitarian device exemption application for its AbioCor implantable replacement heart Sept. 1 and anticipates HDE approval by the end of its fiscal year in March 2005 (1"The Gray Sheet" April 19, 2004, p. 23). Abiomed has enrolled 14 of 15 patients for its clinical trial, the firm also notes Sept. 8...